Frank C. Gibson - Search Results

Year	Number of Results
2002	2
2003	2
2004	2
2005	3
2006	4
2007	3
2008	4
2010	3
2011	1
2012	2
2013	2
2014	3
2016	2
2018	1
2019	2
2020	1
2021	2
2022	1

1

A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss.

Rocha FG, Berges A, Sedra A, Ghods S, Kapoor N, Pill L, Davey ME, Fairman J, Gibson FC 3rd. Rocha FG, et al. Among authors: gibson fc 3rd. Front Oral Health. 2021 Jul 5;2:686402. doi: 10.3389/froh.2021.686402. eCollection 2021. Front Oral Health. 2021. PMID: 35048031 Free PMC article.

2

Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.

Rocha FG, Ottenberg G, Eure ZG, Davey ME, Gibson FC 3rd. Rocha FG, et al. Among authors: gibson fc 3rd. Infect Immun. 2021 Mar 17;89(4):e00614-20. doi: 10.1128/IAI.00614-20. Print 2021 Mar 17. Infect Immun. 2021. PMID: 33361202 Free PMC article.

3

Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems.

Wallet SM, Puri V, Gibson FC. Wallet SM, et al. Among authors: gibson fc. Vaccines (Basel). 2018 Apr 5;6(2):21. doi: 10.3390/vaccines6020021. Vaccines (Basel). 2018. PMID: 29621153 Free PMC article. Review.

4

Cell Wall Hydrolytic Enzymes Enhance Antimicrobial Drug Activity Against Mycobacterium.

Gustine JN, Au MB, Haserick JR, Hett EC, Rubin EJ, Gibson FC 3rd, Deng LL. Gustine JN, et al. Among authors: gibson fc 3rd. Curr Microbiol. 2019 Apr;76(4):398-409. doi: 10.1007/s00284-018-1620-z. Epub 2019 Jan 2. Curr Microbiol. 2019. PMID: 30603964

5

Virulence of the Pathogen Porphyromonas gingivalis Is Controlled by the CRISPR-Cas Protein Cas3.

Solbiati J, Duran-Pinedo A, Godoy Rocha F, Gibson FC 3rd, Frias-Lopez J. Solbiati J, et al. Among authors: gibson fc 3rd. mSystems. 2020 Sep 29;5(5):e00852-20. doi: 10.1128/mSystems.00852-20. mSystems. 2020. PMID: 32994292 Free PMC article.

6

Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.

Gibson FC 3rd, Genco CA. Gibson FC 3rd, et al. Curr Pharm Des. 2007;13(36):3665-75. doi: 10.2174/138161207783018554. Curr Pharm Des. 2007. PMID: 18220804 Review.

7

Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis.

Gibson FC 3rd, Ukai T, Genco CA. Gibson FC 3rd, et al. Front Biosci. 2008 Jan 1;13:2041-59. doi: 10.2741/2822. Front Biosci. 2008. PMID: 17981690 Review.

8

Signaling events in pathogen-induced macrophage foam cell formation.

Shaik-Dasthagirisaheb YB, Mekasha S, He X, Gibson FC 3rd, Ingalls RR. Shaik-Dasthagirisaheb YB, et al. Among authors: gibson fc 3rd. Pathog Dis. 2016 Aug;74(6):ftw074. doi: 10.1093/femspd/ftw074. Epub 2016 Jul 31. Pathog Dis. 2016. PMID: 27481727 Free PMC article.

9

Immunization with cell-free-generated vaccine protects from Porphyromonas gingivalis-induced alveolar bone loss.

Huang N, Shimomura E, Yin G, Tran C, Sato A, Steiner A, Heibeck T, Tam M, Fairman J, Gibson FC 3rd. Huang N, et al. Among authors: gibson fc 3rd. J Clin Periodontol. 2019 Feb;46(2):197-205. doi: 10.1111/jcpe.13047. Epub 2019 Jan 31. J Clin Periodontol. 2019. PMID: 30578564 Free PMC article.

10

Immuno-pathogenesis of Periodontal Disease: Current and Emerging Paradigms.

Huang N, Gibson FC 3rd. Huang N, et al. Among authors: gibson fc 3rd. Curr Oral Health Rep. 2014 Jun 1;1(2):124-132. doi: 10.1007/s40496-014-0017-8. Curr Oral Health Rep. 2014. PMID: 24839590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results